Genericare Medicine Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 01-01-2025
- Paid Up Capital ₹ 0.15 M
as on 01-01-2025
- Company Age 6 Year, 27 Days
- Last Filing with ROC 31 Mar 2024
- Revenue -35.00%
(FY 2022)
- Profit -91.93%
(FY 2022)
- Ebitda -91.93%
(FY 2022)
- Net Worth 6.43%
(FY 2022)
- Total Assets 8.69%
(FY 2022)
About Genericare Medicine
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Bharat Birari and Manoj Birari serve as directors at the Company.
- CIN/LLPIN
U24299MH2018PTC318670
- Company No.
318670
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Genericare Medicine?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharat Birari  | Director | 21-Dec-2018 | Current |
| Manoj Birari | Director | 21-Dec-2018 | Current |
Financial Performance of Genericare Medicine.
Genericare Medicine Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 35% decrease. The company also saw a substantial fall in profitability, with a 91.93% decrease in profit. The company's net worth moved up by a moderate rise of 6.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genericare Medicine?
Unlock access to Genericare Medicine's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Genericare Pharmacy Private LimitedActive 6 years 1 monthBharat Birari and Manoj Birari are mutual person
Future Generic Private LimitedActive 3 years 9 monthsBharat Birari and Manoj Birari are mutual person
- 3Biz Healthcare Private LimitedActive 7 years 11 months
Bharat Birari and Manoj Birari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genericare Medicine?
Unlock and access historical data on people associated with Genericare Medicine, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genericare Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genericare Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
